| Patient | Lou Gehrig |
|---|---|
| Date of birth | 1990-06-19 |
| Identifiers | MRN HR-ET018-SYN; SSN (made up) 000-18-6620 |
| Document date | 2026-10-19 |
| Author | Gavin Hollister, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Five months after diagnosis: breathing tests and ventilation planning, nutrition and gastrostomy, speech, and his new desk work. [S]
Mr. Gehrig returns five months after the diagnosis, on the day of his ALS clinic visit. He started his desk role in city public service two weeks ago with the accommodations in place and works four days a week. He sleeps flat, with no breathlessness, morning headaches or daytime sleepiness, but tires after climbing the stairs. His speech slurs more by evening; he coughs once or twice with thin drinks. His weight is down a little further despite extra calories. The power wheelchair has been approved and is due next month. His hepatitis B and C screening tests from the preventive visit were negative, so he is not immune to hepatitis B and continues the vaccine series today. [S]
| Element | Detail |
|---|---|
| Work | Desk role in public service for two weeks; four days a week; accommodations in place |
| Breathing | No orthopnea, morning headaches or daytime sleepiness; tired after stairs |
| Speech and swallowing | More slurring by evening; occasional cough with thin drinks |
| Weight | Down a little further |
| Results | Hepatitis B and C screening negative |
| System | Result | Finding |
|---|---|---|
| Respiratory | Positive | Tired after stairs; no orthopnea or morning headaches |
| Ears, nose, mouth, and throat | Positive | Slurred speech by evening; occasional cough with thin drinks; no drooling |
| Constitutional | Positive | Weight 86.6 kg; no fever |
| Neurological | Positive | Weaker hands and left leg; no numbness |
| Psychiatric | Negative | Mood steadier since starting work; PHQ-9 6 |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Riluzole 50 mg oral tablet, one tablet by mouth twice daily, an hour before or two hours after meals | One tablet by mouth every 12 hours on an empty stomach | Oral route | 2026-05-18 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food as needed for ankle pain, for up to 5 days | One tablet by mouth every 8 hours with food as needed, up to 5 days | Oral route | 2026-07-20 to 2026-07-25 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-19 | Body height | 183 | cm | S |
| 2026-10-19 | Body weight | 86.6 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 25.9 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 76 | /min | S |
| 2026-10-19 | Respiratory rate | 16 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 | U/L | 7-55 U/L | Normal | S |
| 2026-10-19 | Forced vital capacity [Volume] Respiratory system | 3.69 | L | >=4.1 L | Low | S |
| 2026-10-19 | FVC measured/predicted | 72 | % | 80% of predicted or more is normal; noninvasive ventilation is considered below 50% | Low | S |
| 2026-10-19 | Total score [ALSFRS-R] | 36 | {score} | S | ||
| 2026-10-19 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S |
Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 118/74, pulse 76, oxygen saturation 97%; weight 86.6 kg |
| Neurological | Moderate hand weakness (grip 3+/5); left ankle dorsiflexion 3/5; mild to moderate dysarthria; tongue fasciculations; brisk jaw jerk |
| Respiratory | Clear; slight paradoxical abdominal movement when lying flat |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked | resolved | confirmed | M62.81 | S — Synthetic presenting problem anchored to his documented decline in 1938 and 1939; superseded by the diagnosis. |
| Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosis | active | confirmed | G12.21 | S — Synthetic modern diagnosis; the documented 1939 diagnosis is the anchor. EMG findings, scores and timing are synthetic. |
| Sprain of the left lateral ankle ligaments after tripping on a curb with left foot drop, while not wearing his ankle-foot orthosis: swelling and tenderness over the anterior talofibular ligament, able to bear weight, no bony tenderness by the Ottawa ankle rules; resolved | resolved | confirmed | S93.402A | S — Synthetic injury; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | ALSFRS-R | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | 36 of 48 |
| Imaging | Seated forced vital capacity | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | 3.69 L, 72% of predicted seated; 63% supine |
| Examination | Maximal inspiratory pressure; supine capacity and overnight oximetry when values fall or symptoms appear | Every 2 to 3 months in the multidisciplinary ALS clinic | Ordered | Maximal inspiratory pressure -62 cmH2O; supine FVC 63%; overnight oximetry ordered |
| Examination | Noninvasive ventilation criteria (FVC below 50%, maximal inspiratory pressure weaker than -60 cmH2O, nocturnal desaturation, orthopnea) | Every 2 to 3 months in the multidisciplinary ALS clinic | Due | Not yet met; close on maximal inspiratory pressure; fitting planned as soon as oximetry or tests meet a criterion |
| Examination | Weight and BMI (gastrostomy discussion if weight falls 5 to 10% or swallowing is unsafe; place while FVC is above 50%) | Every visit | Completed today | 86.6 kg, 2.9% below diagnosis; gastrostomy discussed |
| Examination | Speech and swallowing assessment | Every 2 to 3 months in the multidisciplinary ALS clinic | Ordered | Mild to moderate dysarthria; cough with thin liquids; swallowing study ordered |
| Survey | Cognitive and behavioral screening | At diagnosis and periodically | Completed today | Brief screen repeated in clinic; normal |
| Survey | Depression (PHQ-9) | Every visit | Completed today | PHQ-9 6 |
| Examination | Symptoms: cramps, spasticity, saliva, emotional lability, pain | Every visit | Completed today | No drooling or emotional lability; cramps controlled |
| Examination | Mobility, falls, orthoses and equipment | Every visit | Completed today | Orthosis and cane; power wheelchair approved, due next month; no falls |
| Laboratory | ALT on riluzole | Monthly for 3 months, then every 3 months | Completed today | ALT 33 U/L |
| Referral | Multidisciplinary ALS clinic | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | Seen today |
| Self-management | Work, disability benefits and social work | From diagnosis | Completed today | Working four days a week with accommodations |
| Self-management | Advance care planning | Early, then at each change | Completed today | Recorded at the preventive visit; reviewed today with the ventilation and feeding decisions ahead |
| Self-management | Vaccination review | Yearly | Completed today | Influenza and COVID-19 at the preventive visit; second hepatitis B dose today |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), second of two doses [S]
Guideline basis: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function (1999); Adult Immunization Schedule by Medical Condition and Other Indication (2026)
Follow-up: Overnight oximetry and swallowing study within two weeks; respiratory therapist to fit noninvasive ventilation when a criterion is met. Decision on gastrostomy within a month. ALS clinic in about two months. [S]